Non-Profit Create $300 Hep C Cure, For-Profit Cure is $84,000

hands

A for-profit pharmaceutical company sells a hepatitis C cure for $84,000 in the United States, which means that the average person cannot afford it and international the cost of the treatment is out of reach. Globally hepatitis C causes 400,000 deaths a year and affects 71 million people. Pharmaceutical companies claim the high price of their drugs is due to research and development (they spend more on advertising than research), yet non-profits can do similar research for a lot cheaper. Maybe we should only buy medical drugs from non-profits.

The Drugs for Neglected Diseases initiative (DNDi), a not-for-profit organisation, is working with the Egyptian drugmaker Pharco Pharmaceuticals to bring a combination treatment of two hepatitis C tablets, ravidasvir (a new drug)­ and sofosbuvir, to countries that cannot afford to pay the high prices charged by US companies Gilead and AbbVie. This is taking longer than expected but has moved a big step closer with the latest results.


The medicine has also been tested on 300 patients in Egypt, who have different genetic characteristics, with a 100% cure rate. Further studies are being carried out in South Africa and Ukraine to cover all six genotypes of the disease.

Read more.

Leave a Reply

Scroll To Top
%d bloggers like this: